While the United States, Britain and other wealthy countries race to vaccinate their populations against the coronavirus, a new report finds that as much as 90% of the population in dozens of poorer countries could be forced to wait until at least 2022 because wealthy countries are hoarding so much of the vaccine supply. A growing movement is calling for the development of a people’s vaccine and the suspension of intellectual property rights to expand access. We speak with Dr. Mohga Kamal-Yanni, a policy adviser to the People’s Vaccine Alliance, and Achal Prabhala, a public health advocate and coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.
When will we hear our president tell us how he plans to get all this great legislation underway in a Senate that is filled with McConnell and Manchin roadblocks?
Studies prove that such bans will help people quit smoking, especially those disproportionately affected by menthol cigarettes.
While the China model cannot be transplanted to the West, there’s a lot that America can learn from China.
A court has ruled that the EPA must ban the controversial pesticide chlorpyrifos—or prove its safety.